FIELD: pharmaceutics.
SUBSTANCE: invention relates to use of compounds
(N-isopentyloctanamide),
(4-methyl-2-(octanoylamino)pentanoic acid),
or pharmaceutically acceptable salts thereof for preparing a composition for treating mammals for reduction of subcutaneous fat or prevention of accumulation of subcutaneous fat.
EFFECT: invention provides a compound with lipolytic and anti-adipogenic activity, acceptable for preventing and treating cellulite.
12 cl, 4 ex, 7 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE WITH ANTI-OBESITY AND ANTIDIABETIC EFFICACY AND USE THEREOF | 2017 |
|
RU2721426C1 |
| TOPICAL COSMETIC COMPOSITIONS FOR TREATMENT OR PREVENTION OF CELLULITIS | 2009 |
|
RU2478365C1 |
| PROLONGED RELEASE LIPOLYTIC COMPOUNDS FOR LOCAL TREATMENT OF LIPOPEXIA | 2006 |
|
RU2431501C2 |
| USING PHOSPHOLIPID-CONTAINING COMPOSITION FOR REMOVING SUBCUTANEOUS FAT BY SUBCUTANEOUS LYPOLYSIS | 2011 |
|
RU2549966C2 |
| CONJUGATES OF THERAPEUTIC COMPOUND WITH FATTY ACID | 1996 |
|
RU2166512C2 |
| PEPTIDES, APPLIED IN SKIN, MUCOSA AND/OR HAIR TREATMENT AND/OR CARE, AND THEIR APPLICATION IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2557401C2 |
| PHARMACEUTICAL COMPOSITIONS FOR CELLULITIS TREATMENT | 2005 |
|
RU2401098C2 |
| METHOD OF TREATMENT OF CELLULITE | 2011 |
|
RU2571691C2 |
| CONJUGATES: THERAPEUTIC COMPOUND-FATTY ACID | 1994 |
|
RU2137755C1 |
| COMPOSITIONS AND METHODS FOR TOPICAL PROSTAGLANDINS DELIVERY TO SUBCUTANEOUS FAT | 2014 |
|
RU2635864C2 |
